Patents by Inventor Laurent Lagrost

Laurent Lagrost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIPOPROTEINS CONTAINING PLATINUM COMPLEXES FOR THE TREATMENT OF CANCER
    Publication number: 20190110990
    Abstract: The present invention relates to lipoproteins containing platinum complex. The invention also relates to a kit comprising said lipoproteins. In particular, the present invention relates to the use of said platinum-complex-bearing lipoproteins for the specific targeting of macrophages and tumour cells in the treatment of cancer.
    Type: Application
    Filed: May 29, 2017
    Publication date: April 18, 2019
    Inventors: Frédéric LIRUSSI, Carmen GARRIDO-FLEURY, Laurent LAGROST
  • Preparation of recombinant human plasma phospholipid transfer protein (PLTP) from the milk of transgenic rabbits
    Patent number: 9920103
    Abstract: The invention relates to obtaining a preparation of recombinant human PLTP from the milk of a transgenic animal containing in its genome one or more copies of a transgene comprising a polynucleotide coding for human PTLP, placed under transcriptional control of a promoter permitting its specific expression in the cells of the mammary glands of said animal. The recombinant human PLTP preparation obtained can be used in the prevention or treatment of septic shock.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: March 20, 2018
    Assignees: BIOPROTEIN TECHNOLOGIES SA, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Pierre-Jean Ripoll, Laurent Lagrost
  • Preparation of Recombinant Human Plasma Phospholipid Transfer Protein (PLTP) From the Milk of Transgenic Animals
    Publication number: 20130203648
    Abstract: The invention relates to obtaining a preparation of recombinant human PLTP from the milk of a transgenic animal containing in its genome one or more copies of a transgene comprising a polynucleotide coding for human PTLP, placed under transcriptional control of a promoter permitting its specific expression in the cells of the mammary glands of said animal. The recombinant human PLTP preparation obtained can be used in the prevention or treatment of septic shock.
    Type: Application
    Filed: April 6, 2011
    Publication date: August 8, 2013
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), BIOPROTEIN TECHNOLOGIES SA
    Inventors: Pierre-Jean Ripoll, Laurent Lagrost